Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Cetuximab
Matrix: | Human Serum |
Assay Range: | 3.91 - 113 µg/mL |
Sample Volume: | 10 |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Cetuximab
Matrix: | Human Serum |
Assay Range: | 2.50 - 150 ug/mL |
Sample Volume: | 0.01 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -70 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Cetuximab ADA
Matrix: | Human Serum |
Assay Range: | 26.4 ng/mL assay sensitivity |
Sample Volume: | 0.005 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | MSD |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Cevimeline
Matrix: | Human Plasma |
Assay Range: | 0.1 - 100 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Saliva Production |
Classification: | Drug Assays |
Chlorpheniramine
Codeine
Guaifenesin
Codeine
Guaifenesin
Matrix: | Human Plasma |
Assay Range: | 0.1 - 100 ng/mL0.3 - 300 ng/mL1 - 1,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Allergy |
Classification: | Drug Assays |
Chlorzoxazone
Matrix: | Human Plasma |
Assay Range: | 0.2 - 50 µg/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Analgesic |
Classification: | Drug Assays |
Cimetidine
Matrix: | Human Plasma |
Assay Range: | 50 - 5,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antacid |
Classification: | Drug Assays |
Cisplatin
Matrix: | Human Plasma |
Assay Range: | 2.00 - 1,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Cisplatin
Matrix: | Human Plasma Ultrafiltrate |
Assay Range: | 2.00 - 1,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Cisplatin
Matrix: | Monkey Plasma |
Assay Range: | 1.00 - 10,000 ng/mL |
Sample Volume: | 0.04 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Cisplatin
Matrix: | Human Plasma |
Assay Range: | 1.00 - 1,000 ngPt/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA Heparin |
Storage Temperature (°C): | -20 & -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Cisplatin
Matrix: | Human Plasma Ultrafiltrate |
Assay Range: | 1.00 - 1,000 ngPt/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTAHeparin |
Storage Temperature (°C): | -20 & -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Cisplatin
Matrix: | Human Plasma Ultrafiltrate |
Assay Range: | 2.00 - 1,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Citalopram
Matrix: | Human Plasma |
Assay Range: | 0.500 - 250 ng/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
CK18 capsase-cleaved (M30)
Matrix: | Human Serum |
Assay Range: | 50 - 1,000 U/L |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
CK18 total (M65)
Matrix: | Human Serum |
Assay Range: | 25 - 2,000 U/L |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Clarithromycin
Matrix: | Human Plasma |
Assay Range: | 25 - 10,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Clopidogrel
Matrix: | Human Plasma |
Assay Range: | 0.1 - 10 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Cocaine
Benzoylecgonine
Benzoylecgonine
Matrix: | Human Plasma |
Assay Range: | 5 - 500 ng/mL 10 - 1,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Stimulant |
Classification: | Drug Assays |
Colchicine
Matrix: | Human Plasma |
Assay Range: | 40 - 8,000 pg/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Gout |
Classification: | Biochemical Biomarkers |
Complement 3a (C3a)
Matrix: | Human Plasma |
Assay Range: | 10.0 - 974 ng/mL |
Sample Volume: | 10 µL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Complement 4 (C4)
Matrix: | Human Plasma |
Assay Range: | 14.5 - 1,856 µg/mL |
Sample Volume: | 0.08 mL |
Anti-Coagulant: | Citrate |
Storage Temperature (°C): | -70 |
Platform: | Nephelometry |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Complement 5a (C5a)
Matrix: | Human Plasma |
Assay Range: | 2.08 - 19.7 ng/mL |
Sample Volume: | 20 µL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Complement Total (CH50)
Matrix: | Human Serum |
Assay Range: | 34 - 304 U eq/mL |
Sample Volume: | 30 µL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Copper
Matrix: | Human Urine |
Assay Range: | 50.0 - 800 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -80 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT